Search
for
Sort by
Research 151–180 of 584
- Alopecia areata: a review on diagnosis, immunological etiopathogenesis and treatment options
- Artepillin C and Other Herbal PAK1-blockers: Effects on Hair Cell Proliferation and Related PAK1-dependent Biological Function in Cell Culture
- Antioxidant and 5α-Reductase Inhibitory Activity of Momordica charantia Extract, and Development and Characterization of Microemulsion
- Case Report: Vitiligo and Alopecia Universalis Following Rituximab Therapy in a Patient with Myasthenia Gravis
- Precision therapeutics in non-scarring alopecia: a systemic genomic and pathway-based framework for targeted interventions
- Modern Management Approaches for Alopecia Areata
- Farmácia Padrão da Légua, Custóias e nos Serviços Farmacêuticos da Klinicka Bolnica Dubrava, Croácia
- P88 Real-world evidence on efficacy and safety of Janus Kinase inhibitors in the treatment of moderate to severe active Ulcerative Colitis
- Molecular crosstalk between lncRNA H19, miR-29a, and JAK2/STAT3 signaling in alopecia areata: a preliminary study
- A Subset of TREM2+ Dermal Macrophages Secretes Oncostatin M to Maintain Hair Follicle Stem Cell Quiescence and Inhibit Hair Growth
- The use of topical ruxolitinib 1.5% cream in frontal fibrosing alopecia: A case report
- Oral abrocitinib for treatment of refractory alopecia areata: A retrospective study
- Inibidores das Janus Associated Kinases na Terapêutica Farmacológica
- LB1034 Meta-analysis of scalp transcriptome defines alopecia areata subtypes and molecular response to four (4) treatments with jak inhibiting properties
- Case report: Dupilumab therapy for alopecia areata in a 4-year-old patient resistant to baricitinib
- Baricitinib Effectiveness in JAKi‐Naïve and Tofacitinib‐Exposed Patients: A Prospective Study in Alopecia Areata
- Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition
- Targeting the Janus Kinase Family in Autoimmune Skin Diseases
- Tyrosine Kinases in Autoimmune and Inflammatory Skin Diseases
- Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata
- JAK inhibition in the treatment of alopecia areata – a promising new dawn?
- Alopecia Areata: A Review of the Role of Oxidative Stress, Possible Biomarkers, and Potential Novel Therapeutic Approaches
- Induction of T cell exhaustion by JAK1/3 inhibition in the treatment of alopecia areata
- Hair regrowth in alopecia areata and re‐pigmentation in vitiligo in response to treatment: Commonalities and differences
- Treatments for Moderate-to-Severe Alopecia Areata: A Systematic Narrative Review
- Forging the Future: 2018 Alopecia Areata Research Summit Summary Report
- “<i>Nomen Omen</i>: The Myth of God Janus”
- Comprehensive Safety Exposure‐Response Analysis to Support Ritlecitinib Dose Selection
- Pharmacologic inhibition of JAK-STAT signaling promotes hair growth
- Off-Label Uses of Abrocitinib: Review of Emerging Therapeutic Applications beyond Atopic Dermatitis